Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State

Summary

This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter referred to as GZR33) and estimate its potency in comparison with insulin degludec.

Timeline

Start

2025-10-13

Primary completion

2026-02-28

Completion

2026-04-15

Drugs

Indications